doi:10.3969/j.issn.1673-8640.2020.08.012

Abstract

CLC Number:

R446.1

. [J]. Laboratory Medicine, 2020, 35(8): 795-798.

Figures/Tables 3

References 15

[1]	LOUDEN K A,BROUGHTON PIPKIN F,HEPTINSTALL S,et al. A longitudinal study of platelet behavior and thromboxane production in whole blood in normal pregnancy and the puerperium[J]. Br J Obstet Gynaecol,1990,97(12):1108-1114.
[2]	BRENNER B. Clinical management of thrombophilia-related placental vascular complications[J]. Blood,2004,103(11):4003-4009.
[3]	夏丽波,简翠,张碧玉,等. 儿童血栓弹力图参考区间建立及与常规凝血项目的比较[J]. 检验医学,2017,32(2):81-85.
[4]	赵英妹,张珏,黄燕. 年龄和性别对健康人群血栓弹力图参数的影响[J]. 检验医学,2019,34(10):881-884.
[5]	SHARMA S K,PHILIP J,WILEY J. Thromboelastographic changes in healthy parturients and postpartum women[J]. Anesth Analg,1997,85(1):94-98.
[6]	Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory[S]. C28-A3E,CLSI,2008.
[7]	龚波,章莉,戴云,等. 正常妊娠妇女血栓弹力图参考范围的建立[J]. 诊断学理论与实践,2012,11(5):490-493.
[8]	唐浩,傅云峰,桂嵘. 孕妇血栓弹力图正常值参考范围的建立[J]. 中国输血杂志,2017,30(7):687-689.
[9]	ANTONY K M,MANSOURI R,ARNDT M,et al. Establishing thromboelastography with platelet-function analyzer reference ranges and other measures in healthy term pregnant women[J]. Am J Perinatol,2015,32(6):545-554.
[10]	周莉,范玲. 妊娠期凝血功能特点[J]. 中华产科急救电子杂志,2014,3(2):81-85.
[11]	BOEHLEN F,HOHLFELD P,EXTERMANN P,et al. Platelet count at term pregnancy:a reappraisal of the threshold[J]. Obstet Gynecol,2000,95(1):29-33.
[12]	周希亚,刘俊涛. 妊娠期凝血机能的调节[J]. 实用妇产科杂志,2016,32(9):643-645.
[13]	LEE S,HUH S J,OH S Y,et al. Clinical significance of coagulation factors in operable colorectal cancer[J]. Oncol Lett,2017,13(6):4669-4674 .
[14]	秦秀云,贾晶. 妊娠期高血压疾病患者凝血功能指标、血栓前状态指标水平变化及意义[J]. 山东医药,2018,58(21):72-74.
[15]	许亚莉,万春晶,王宝燕. 血栓弹力图及常规凝血检测对妊娠期妇女凝血状态的评价[J]. 临床血液学杂志(输血与检验),2016,29(5):781-784.

凝血指标	R值	K值	α角	MA值	CI值
PT	0.175^**	0.041	-0.051	-0.047	0.055
APTT	0.043	-0.062	-0.014	-0.015	-0.044
TT	0.052	-0.035	0.012	0.014	0.045
Fib	-0.034	-0.072	0.162^**	0.269^**	-0.049
PLT计数	-0.065	-0.097	0.216^*	0.316^**	0.052

凝血指标	R值	K值	α角	MA值	CI值
PT	0.175^**	0.041	-0.051	-0.047	0.055
APTT	0.043	-0.062	-0.014	-0.015	-0.044
TT	0.052	-0.035	0.012	0.014	0.045
Fib	-0.034	-0.072	0.162^**	0.269^**	-0.049
PLT计数	-0.065	-0.097	0.216^*	0.316^**	0.052

组别	例数	R值/min	K值/min	α角/°	MA值/min	CI值
对照组	122	3.5~7.1	1.6~2.0	49.3~82.4	45.8~78.8	-3.5~5.2
早孕组	123	2.2~7.7	0.8~2.2	55.3~78.3	58.5~71.8	-1.2~4.1
中孕组	158	2.3~6.5	0.7~2.1	62.1~78.9	52.4~78.5	-0.1~4.6
晚孕组	187	2.5~6.0	0.4~2.3	61.1~81.8	54.6~77.0	0.0~4.8

组别	例数	R值/min	K值/min	α角/°	MA值/min	CI值
对照组	122	3.5~7.1	1.6~2.0	49.3~82.4	45.8~78.8	-3.5~5.2
早孕组	123	2.2~7.7	0.8~2.2	55.3~78.3	58.5~71.8	-1.2~4.1
中孕组	158	2.3~6.5	0.7~2.1	62.1~78.9	52.4~78.5	-0.1~4.6
晚孕组	187	2.5~6.0	0.4~2.3	61.1~81.8	54.6~77.0	0.0~4.8

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.